<DOC>
	<DOCNO>NCT00238706</DOCNO>
	<brief_summary>The aim prospective randomize clinical trial evaluate early late outcome follow leave atrial radiofrequency ablation MV surgery treatment continuous atrial fibrillation ass functional effect restoration sinus rhythm .</brief_summary>
	<brief_title>Use Radiofrequency Ablation Eliminate Continuous Atrial Fibrillation Patients Undergoing Mitral Valve Surgery</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) frequent important contributor symptom morbidity patient mitral valve ( MV ) disease.Radiofrequency ablation ( RFA ) leave atrium ( LA ) open- heart surgery emerge novel surgical modality treatment AF . Although RFA therapy LA increasingly offer patient chronic AF undergo MV surgery , efficacy test context adequately power randomize study . The aim prospective randomize clinical trial evaluate early late outcome follow leave atrial RFA MV surgery treatment continuous AF ass functional effect restoration SR . Patients randomize undergo MV surgery MV surgery plus RFA LA . Additional cardiac procedure perform require . The primary outcome endpoint presence SR 12 month . Secondary endpoint include patient functional status exercise capacity , LA contractility , LA leave ventricular ( LV ) dimension function plasma level B-Type natriuretic peptide ( BNP ) .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients require MV surgery least 6 month history atrial fibrillation Patients sick sinus syndrome Hyperthyroidism Permanent pacemaker Previous cardiac surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Radiofrequency catheter ablation</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Randomized trial</keyword>
</DOC>